Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Results from an Open-Label Phase 2a Study of Cerdulatinib, a Dual Spleen Tyrosine Kinase/janus Kinase Inhibitor, in Relapsed/refractory Peripheral T-cell Lymphoma

Steven M. Horwitz,Tatyana A. Feldman,Jing Christine Ye,Michael S. Khodadoust,Javier Munoz,Paul A. Hamlin,Youn H. Kim,Ryan A. Wilcox,Manish R. Patel,Greg Coffey, Alison Innes,Andreas Betz, Jaymes Holland,Cristina B. Guzman,Sonali M. Smith

LEUKEMIA & LYMPHOMA（2025）

Cited 0|Views3
Key words
Peripheral T-cell lymphoma,dual spleen tyrosine kinase/janus kinase inhibitor,phase-2 study,relapsed/refractory
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined